CN114605440B - 一种咔唑基镓咔咯衍生物的制备方法及在光动力抗菌和抗肿瘤中的应用 - Google Patents
一种咔唑基镓咔咯衍生物的制备方法及在光动力抗菌和抗肿瘤中的应用 Download PDFInfo
- Publication number
- CN114605440B CN114605440B CN202210314872.XA CN202210314872A CN114605440B CN 114605440 B CN114605440 B CN 114605440B CN 202210314872 A CN202210314872 A CN 202210314872A CN 114605440 B CN114605440 B CN 114605440B
- Authority
- CN
- China
- Prior art keywords
- carbazolyl
- gallium
- carbole
- derivative
- photodynamic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 carbazolyl gallium Chemical compound 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 229910052733 gallium Inorganic materials 0.000 title claims description 19
- 230000000259 anti-tumor effect Effects 0.000 title abstract description 15
- 230000003115 biocidal effect Effects 0.000 title abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 14
- 241000588724 Escherichia coli Species 0.000 claims abstract description 12
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 7
- 238000005286 illumination Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 5
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 208000026310 Breast neoplasm Diseases 0.000 claims description 3
- 229940124350 antibacterial drug Drugs 0.000 claims description 2
- 241000191940 Staphylococcus Species 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 15
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 abstract description 12
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 abstract description 4
- UPWPDUACHOATKO-UHFFFAOYSA-K gallium trichloride Chemical compound Cl[Ga](Cl)Cl UPWPDUACHOATKO-UHFFFAOYSA-K 0.000 abstract description 2
- 238000006482 condensation reaction Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 229910052786 argon Inorganic materials 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000001716 carbazoles Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 231100000018 phototoxicity Toxicity 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MNLZGFHCFGWITO-UHFFFAOYSA-N 9-butylcarbazole-3-carbaldehyde Chemical compound O=CC1=CC=C2N(CCCC)C3=CC=CC=C3C2=C1 MNLZGFHCFGWITO-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Natural products C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 1
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- CSCPPACGZOOCGX-WFGJKAKNSA-N deuterated acetone Substances [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210314872.XA CN114605440B (zh) | 2022-03-28 | 2022-03-28 | 一种咔唑基镓咔咯衍生物的制备方法及在光动力抗菌和抗肿瘤中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210314872.XA CN114605440B (zh) | 2022-03-28 | 2022-03-28 | 一种咔唑基镓咔咯衍生物的制备方法及在光动力抗菌和抗肿瘤中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114605440A CN114605440A (zh) | 2022-06-10 |
CN114605440B true CN114605440B (zh) | 2024-01-05 |
Family
ID=81866805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210314872.XA Active CN114605440B (zh) | 2022-03-28 | 2022-03-28 | 一种咔唑基镓咔咯衍生物的制备方法及在光动力抗菌和抗肿瘤中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114605440B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110128430A (zh) * | 2019-05-31 | 2019-08-16 | 南京林业大学 | 一种8-羟基喹啉基咔咯镓配合物pH荧光探针及其制备方法 |
CN111961067A (zh) * | 2020-09-02 | 2020-11-20 | 南京林业大学 | 一种偶氮基双咔咯衍生物及其制备方法 |
CN112457334A (zh) * | 2020-12-07 | 2021-03-09 | 南京林业大学 | 一种邻菲啰啉桥联双咔咯衍生物的制备方法 |
-
2022
- 2022-03-28 CN CN202210314872.XA patent/CN114605440B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110128430A (zh) * | 2019-05-31 | 2019-08-16 | 南京林业大学 | 一种8-羟基喹啉基咔咯镓配合物pH荧光探针及其制备方法 |
CN111961067A (zh) * | 2020-09-02 | 2020-11-20 | 南京林业大学 | 一种偶氮基双咔咯衍生物及其制备方法 |
CN112457334A (zh) * | 2020-12-07 | 2021-03-09 | 南京林业大学 | 一种邻菲啰啉桥联双咔咯衍生物的制备方法 |
Non-Patent Citations (1)
Title |
---|
meso-Indolo[3,2-b]carbazolyl-Substituted Porphyrinoids: Synthesis, Characterization and Effect of the Number of Indolocarbazole Moieties on the Photophysical Properties;Wouter Maes 等;European Journal of Organic Chemistry;2576-2586 * |
Also Published As
Publication number | Publication date |
---|---|
CN114605440A (zh) | 2022-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109575061A (zh) | 一种水溶性的抗癌光敏剂及其制备和应用 | |
CN113461740B (zh) | 一种铱配合物及其制备方法和应用 | |
CN110372754A (zh) | 一种新型金属铱配合物及其制备方法和应用 | |
CN113200913B (zh) | 一种光激活i型光敏剂及其制备方法和应用 | |
CN113698416A (zh) | 一类抑制β-淀粉样蛋白聚集的单线态氧载体及其制备方法和应用 | |
CN114605440B (zh) | 一种咔唑基镓咔咯衍生物的制备方法及在光动力抗菌和抗肿瘤中的应用 | |
CN110423260B (zh) | 一种葡萄糖修饰的环金属化铱光敏剂及其制备方法和应用 | |
KR20040083098A (ko) | 종양 선택성이 높은 신규한 수용성 포르피린 백금 화합물및 양성 및 악성 종양 질환을 치료하기 위한 이의 용도 | |
CN116284146A (zh) | 联喹啉-菲啰啉类钌配合物及其制备方法与应用 | |
CN114656453A (zh) | 七甲川吲哚花菁-tempo化学偶链小分子和制备方法及其制备辐射防护制剂的应用 | |
CN111592560A (zh) | 一种光敏剂探针及其制备方法与应用 | |
RU2402554C2 (ru) | Карборанильные производные фторированных порфиринов и их металлокомплексы, проявляющие свойства фотосенсибилизатора, и способ их получения | |
CN114671870B (zh) | 一种肉桂醛衍生物及其制备方法和应用 | |
Defant et al. | Design, Synthesis and Antimicrobial Evaluation of New Norfloxacin-Naphthoquinone Hybrid Molecules | |
CN113583057B (zh) | 一种高效金属铱配合物及其制备方法和应用 | |
CN114957105B (zh) | 一种双羰基配体及其制备方法和应用 | |
CN114644665B (zh) | 一种光/pH双重响应偶联药物前体化合物及其制备方法和应用 | |
RU2725876C1 (ru) | Производные фторсодержащих хлоринов, проявляющие противоопухолевую активность | |
CN113603726B (zh) | 一种双核铱配合物及其制备方法和应用 | |
CN114409712B (zh) | 一种含大麻二酚Pt(Ⅳ)配合物及其制备方法和应用 | |
CN113603740B (zh) | 一种采用橙色光激发铱配合物及其制备方法和应用 | |
CN112500437B (zh) | 环氧铂配合物及其制备方法和用途 | |
CN114835706B (zh) | 一种n^n配体及其应用 | |
CN115583977A (zh) | 一种新型的双核钌配合物及其制备方法和抗肿瘤应用 | |
CN107011336B (zh) | 一类以吡啶为质子化位点的pH荧光探针及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231212 Address after: Room 1001-12, Building E, No. 9 East Outer Ring Road, Jiangyin City, Wuxi City, Jiangsu Province, 214400 Applicant after: Qilin Biology (Jiangyin) Co.,Ltd. Address before: 518000 1002, Building A, Zhiyun Industrial Park, No. 13, Huaxing Road, Henglang Community, Longhua District, Shenzhen, Guangdong Province Applicant before: Shenzhen Wanzhida Technology Co.,Ltd. Effective date of registration: 20231212 Address after: 518000 1002, Building A, Zhiyun Industrial Park, No. 13, Huaxing Road, Henglang Community, Longhua District, Shenzhen, Guangdong Province Applicant after: Shenzhen Wanzhida Technology Co.,Ltd. Address before: Longpan road Xuanwu District of Nanjing city of Jiangsu Province, No. 159 210037 Applicant before: NANJING FORESTRY University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |